Tatva Chintan Pharma Chem Limited - Asset Resilience Ratio
Tatva Chintan Pharma Chem Limited (TATVA) has an Asset Resilience Ratio of 0.58% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check TATVA PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2025)
This chart shows how Tatva Chintan Pharma Chem Limited's Asset Resilience Ratio has changed over time. See TATVA equity to assets ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Tatva Chintan Pharma Chem Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see TATVA market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs53.09 Million | 0.58% |
| Total Liquid Assets | Rs53.09 Million | 0.58% |
Asset Resilience Insights
- Limited Liquidity: Tatva Chintan Pharma Chem Limited maintains only 0.58% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Tatva Chintan Pharma Chem Limited Industry Peers by Asset Resilience Ratio
Compare Tatva Chintan Pharma Chem Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Akzo Nobel NV
AS:AKZA |
Specialty Chemicals | 2.16% |
|
AKZO NOBEL SPONS.ADRS 1/3
F:AKUP |
Specialty Chemicals | 1.74% |
|
Air Products and Chemicals Inc
NYSE:APD |
Specialty Chemicals | 2.49% |
|
Shandong Dongyue Organosilicon Mat
SHE:300821 |
Specialty Chemicals | 0.00% |
|
Shenzhen Capchem Tech
SHE:300037 |
Specialty Chemicals | 3.18% |
|
Huaibei Mining Holdings Co Ltd
SHG:600985 |
Specialty Chemicals | 2.33% |
|
Lily Group Co Ltd
SHG:603823 |
Specialty Chemicals | 0.37% |
|
Tangshan Sanyou Chemical Industries Co Ltd
SHG:600409 |
Specialty Chemicals | 0.08% |
Annual Asset Resilience Ratio for Tatva Chintan Pharma Chem Limited (2018–2025)
The table below shows the annual Asset Resilience Ratio data for Tatva Chintan Pharma Chem Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 0.04% | Rs3.27 Million ≈ $35.36K |
Rs8.36 Billion ≈ $90.44 Million |
-1.23pp |
| 2024-03-31 | 1.27% | Rs103.64 Million ≈ $1.12 Million |
Rs8.19 Billion ≈ $88.54 Million |
-0.57pp |
| 2023-03-31 | 1.83% | Rs138.50 Million ≈ $1.50 Million |
Rs7.56 Billion ≈ $81.79 Million |
+1.71pp |
| 2022-03-31 | 0.12% | Rs8.02 Million ≈ $86.73K |
Rs6.58 Billion ≈ $71.19 Million |
-0.15pp |
| 2021-03-31 | 0.27% | Rs8.43 Million ≈ $91.17K |
Rs3.15 Billion ≈ $34.04 Million |
-0.17pp |
| 2020-03-31 | 0.44% | Rs10.92 Million ≈ $118.10K |
Rs2.49 Billion ≈ $26.92 Million |
-4.12pp |
| 2019-03-31 | 4.55% | Rs85.40 Million ≈ $923.57K |
Rs1.88 Billion ≈ $20.28 Million |
+3.63pp |
| 2018-03-31 | 0.93% | Rs13.38 Million ≈ $144.70K |
Rs1.44 Billion ≈ $15.62 Million |
-- |
About Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and br… Read more